X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (463) 463
Patent (360) 360
Newspaper Article (276) 276
Publication (56) 56
Book / eBook (50) 50
Magazine Article (34) 34
Dissertation (17) 17
Trade Publication Article (14) 14
Book Review (13) 13
Book Chapter (12) 12
Conference Proceeding (6) 6
Web Resource (4) 4
Newsletter (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (313) 313
organic chemistry (309) 309
metallurgy (306) 306
human necessities (294) 294
hygiene (294) 294
medical or veterinary science (293) 293
preparations for medical, dental, or toilet purposes (293) 293
specific therapeutic activity of chemical compounds ormedicinal preparations (257) 257
humans (200) 200
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (191) 191
index medicus (141) 141
heterocyclic compounds (126) 126
male (126) 126
female (121) 121
microbiology (79) 79
biochemistry (76) 76
middle aged (76) 76
physics (75) 75
enzymology (74) 74
beer (73) 73
compositions thereof (73) 73
culture media (73) 73
microorganisms or enzymes (73) 73
mutation or genetic engineering (73) 73
propagating, preserving or maintaining microorganisms (73) 73
spirits (73) 73
vinegar (73) 73
wine (73) 73
aged (70) 70
adult (69) 69
animals (61) 61
surgery (52) 52
investigating or analysing materials by determining theirchemical or physical properties (45) 45
measuring (45) 45
testing (45) 45
research (44) 44
stroke (44) 44
acyclic or carbocyclic compounds (38) 38
adolescent (37) 37
otorhinolaryngology (36) 36
article (35) 35
care and treatment (34) 34
aged, 80 and over (33) 33
treatment outcome (33) 33
clinical neurology (32) 32
retrospective studies (32) 32
analysis (30) 30
child (30) 30
management (29) 29
risk factors (29) 29
calculating (26) 26
cancer (26) 26
computing (26) 26
counting (26) 26
chemistry, medicinal (25) 25
diagnosis (25) 25
follow-up studies (24) 24
rats (22) 22
mortality (21) 21
medicine & public health (20) 20
oncology (20) 20
disease (19) 19
health aspects (19) 19
neurosciences (19) 19
peptides (19) 19
abridged index medicus (18) 18
magnetic resonance imaging (18) 18
mice (18) 18
chemistry, organic (17) 17
children (17) 17
prospective studies (17) 17
therapy (17) 17
time factors (17) 17
united states (17) 17
handling record carriers (16) 16
neurology (16) 16
presentation of data (16) 16
recognition of data (16) 16
record carriers (16) 16
tumors (16) 16
young adult (16) 16
astronomy & astrophysics (15) 15
ischemia (15) 15
patients (15) 15
pediatrics (15) 15
physiological aspects (15) 15
structure-activity relationship (15) 15
internal medicine (14) 14
psychology (14) 14
apparatus therefor (13) 13
astrophysics (13) 13
endocrinology & metabolism (13) 13
general methods of organic chemistry (13) 13
peripheral vascular disease (13) 13
prognosis (13) 13
usage (13) 13
acute ischemic-stroke (12) 12
cardiac & cardiovascular systems (12) 12
complications (12) 12
diabetes (12) 12
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
UofT at Mississauga - Stacks (7) 7
UofT at Scarborough - Stacks (7) 7
Robarts - Stacks (6) 6
UTL at Downsview - May be requested (6) 6
OISE - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Online Resources - Online (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Toronto East General Hospital - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Art - Library use only (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Humber River Regional Hospital - Finch Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Music - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Reserve desk (1) 1
Regis College - Stacks (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Robarts - Reference (1) 1
Royal Ontario Museum - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Augustine's Seminary - Reference (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Stacks (1) 1
Trinity College (John W Graham) - Reference (1) 1
Victoria University E.J. Pratt - Storage (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1129) 1129
French (92) 92
German (54) 54
Spanish (18) 18
Finnish (14) 14
Swedish (9) 9
Norwegian (8) 8
Portuguese (8) 8
Danish (6) 6
Latvian (6) 6
Czech (5) 5
Turkish (5) 5
Chinese (4) 4
Estonian (4) 4
Hungarian (4) 4
Italian (4) 4
Bulgarian (3) 3
Greek (2) 2
Indonesian (2) 2
Korean (2) 2
Lithuanian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 5/2013, Volume 340, Issue 6132, pp. 626 - 630
The recent discovery of mutations in metabolic enzymes has rekindled interest in harnessing the altered metabolism of cancer cells for cancer therapy. One... 
Enzymes | Cell growth | Glioma | RNA | Neurons | REPORTS | Methylation | Cellular differentiation | Genetic mutation | Heterologous transplantation | Tumors | TRANSFORMATION | GLIOBLASTOMA | MULTIDISCIPLINARY SCIENCES | INTEGRATED GENOMIC ANALYSIS | PHENOTYPE | ACUTE MYELOID-LEUKEMIA | MUTATIONS | ONCOMETABOLITE 2-HYDROXYGLUTARATE | BRAIN | Benzeneacetamides - toxicity | Protein Multimerization | Imidazoles - administration & dosage | Gene Expression Profiling | Isocitrate Dehydrogenase - antagonists & inhibitors | Glioma - genetics | RNA Interference | Enzyme Inhibitors - toxicity | Glioma - pathology | Imidazoles - toxicity | Gene Expression Regulation, Neoplastic - drug effects | Benzeneacetamides - pharmacology | Mutant Proteins - antagonists & inhibitors | Glioma - enzymology | Enzyme Inhibitors - pharmacology | Isocitrate Dehydrogenase - genetics | Mutant Proteins - metabolism | Imidazoles - pharmacology | Mice, SCID | Benzeneacetamides - administration & dosage | Xenograft Model Antitumor Assays | Animals | Cell Differentiation - drug effects | Cell Transformation, Neoplastic | Isocitrate Dehydrogenase - chemistry | Mutant Proteins - chemistry | Isocitrate Dehydrogenase - metabolism | Glutarates - metabolism | Mice | Histones - metabolism | Glioma - drug therapy | Cell proliferation | Gene mutations | Gliomas | Growth | Cancer cells | Physiological aspects | Genetic aspects | Research | Cancer | Genes | Cells | Mutation | Drugs | Binding | Mutations | Inhibitors | Online | Delay
Journal Article
Science, ISSN 0036-8075, 5/2013, Volume 340, Issue 6132, pp. 622 - 626
A number of human cancers harbor somatic point mutations in the genes encoding isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2). These mutations alter... 
Molecules | Enzymes | Dehydrogenases | Blasts | Myeloid leukemia | REPORTS | Stem cells | Bone marrow cells | Cellular differentiation | Hematopoietic stem cells | Mesenchymal stem cells | ISOCITRATE DEHYDROGENASE | ONCOMETABOLITE 2-HYDROXYGLUTARATE | SUFFICIENT | MULTIDISCIPLINARY SCIENCES | HEMATOPOIETIC PROGENITORS | MUTATION | Cell Proliferation | Humans | Protein Multimerization | Crystallography, X-Ray | Erythropoiesis - drug effects | Isocitrate Dehydrogenase - antagonists & inhibitors | Molecular Targeted Therapy | Hematopoiesis - drug effects | Antineoplastic Agents - metabolism | Leukemia, Myeloid, Acute - enzymology | Phenylurea Compounds - chemistry | Enzyme Inhibitors - chemistry | Leukemia, Myeloid, Acute - drug therapy | Antineoplastic Agents - pharmacology | Phenylurea Compounds - metabolism | Mutant Proteins - antagonists & inhibitors | Catalytic Domain | Enzyme Inhibitors - metabolism | Protein Structure, Secondary | Sulfonamides - chemistry | Leukemia, Myeloid, Acute - pathology | Cells, Cultured | Enzyme Inhibitors - pharmacology | Isocitrate Dehydrogenase - genetics | Mutant Proteins - metabolism | Gene Expression Regulation, Leukemic | Antineoplastic Agents - chemistry | Sulfonamides - pharmacology | Point Mutation | Isocitrate Dehydrogenase - chemistry | Small Molecule Libraries | Mutant Proteins - chemistry | Allosteric Site | Sulfonamides - metabolism | Cell Line, Tumor | Isocitrate Dehydrogenase - metabolism | Glutarates - metabolism | Phenylurea Compounds - pharmacology | Leukemia, Erythroblastic, Acute | Leukemia, Myeloid, Acute - genetics | Leukemia | Cancer cells | Physiological aspects | Research | Oxidoreductases | Cell differentiation | Health aspects | Mutation | Cellular biology | Drug therapy | Cells
Journal Article
Nature, ISSN 0028-0836, 07/2018, Volume 559, Issue 7712, pp. 125 - 129
Somatic mutations in the isocitrate dehydrogenase 2 gene (IDH2) contribute to the pathogenesis of acute myeloid leukaemia (AML) through the production of the... 
LUNG-CANCER | CELLS | GEFITINIB | MUTANT IDH2 | MULTIDISCIPLINARY SCIENCES | ACUTE MYELOID-LEUKEMIA | DIFFERENTIATION | (R)-2-HYDROXYGLUTARATE | ENASIDENIB | Triazines - therapeutic use | Humans | Glutarates - blood | Isocitrate Dehydrogenase - antagonists & inhibitors | Aminopyridines - chemistry | Aminopyridines - therapeutic use | Enzyme Inhibitors - chemistry | HEK293 Cells | Protein Multimerization - genetics | Leukemia, Myeloid, Acute - drug therapy | Female | Triazines - chemistry | Mutant Proteins - antagonists & inhibitors | Allosteric Site - genetics | Triazines - pharmacology | Allosteric Site - drug effects | Mice, Inbred C57BL | Enzyme Inhibitors - pharmacology | Mutant Proteins - genetics | Models, Molecular | Isocitrate Dehydrogenase - genetics | Leukemia, Myeloid, Acute - blood | Enzyme Inhibitors - therapeutic use | Disease Progression | Isoleucine - genetics | Drug Resistance, Neoplasm - genetics | Animals | Aminopyridines - pharmacology | Alleles | Glutamine - genetics | Glutarates - metabolism | Mice | Mutation | Clinical Trials, Phase I as Topic | Clinical Trials, Phase II as Topic | Drug Resistance, Neoplasm - drug effects | Leukemia, Myeloid, Acute - genetics | Antimitotic agents | Pharmaceutical research | Research | Drug resistance | Antineoplastic agents | Glutamine | Plasma | Pathogenesis | Leukemia | Lung cancer | Cloning | Neutrophils | Kinases | Cancer therapies | Patients | Proteins | Disease resistance | Allosteric properties | Inhibitors | Bone marrow | Dimers | Inhibition | Target acquisition | Isocitrate dehydrogenase | Isoleucine | Neutropenia | AG-120 | cancer metabolism | leukemia | AG-221 | metabolite | enasidenib | epigenetic | IDH1 | IDH2 | glioma | ivosidenib
Journal Article
Nature Communications, ISSN 2041-1723, 12/2019, Volume 10, Issue 1, pp. 96 - 14
Journal Article
Nature, ISSN 0028-0836, 04/2018, Volume 556, Issue 7702, pp. 501 - 504
Journal Article
Science, ISSN 0036-8075, 10/1998, Volume 282, Issue 5389, pp. 751 - 754
Journal Article
Cancer Discovery, ISSN 2159-8274, 05/2017, Volume 7, Issue 5, pp. 478 - 493
Journal Article